Researchers said the results suggest UnitedHealth may be sidestepping government rules meant to keep a lid on exorbitant ...

Leaders are worried some of the sector’s persistent challenges — like finance pressures and worker burnout — could worsen ...

The $600 million deal was foreshadowed during the company’s third quarter earnings call this month, when CEO Kevin Hammons ...

Fewer than 30% of health system leaders said they earned significant return on investment from virtual care offerings, ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Executives expect insurance coverage availability will be “largely national” by the end of 2026. The initiative is important ...

Overall, Cigna expects earnings to grow next year after posting a solid third quarter. But investments in a new PBM model and ...

Dr. Cliff Deveny announced the transition less than a month after General Catalyst finalized its $515 million acquisition of Summa.

The goodwill impairment charge is meant to realign Centene’s value on its own books with its value in the market, which has ...

The agency will no longer require studies comparing copycat biologics to their branded counterparts, which could help ...